Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, Nelson WG, Yegnasubramanian S, Luo J, Wang Y, Xu J, Isaacs WB, Visakorpi T, Bova GS. Liu W, et al. Among authors: yegnasubramanian s. Nat Med. 2009 May;15(5):559-65. doi: 10.1038/nm.1944. Epub 2009 Apr 12. Nat Med. 2009. PMID: 19363497 Free PMC article.
MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression.
Chen J, Zheng Q, Hicks JL, Trabzonlu L, Ozbek B, Jones T, Vaghasia AM, Larman TC, Wang R, Markowski MC, Denmeade SR, Pienta KJ, Hruban RH, Antonarakis ES, Gupta A, Dang CV, Yegnasubramanian S, De Marzo AM. Chen J, et al. Among authors: yegnasubramanian s. JCI Insight. 2023 Dec 22;8(24):e169868. doi: 10.1172/jci.insight.169868. JCI Insight. 2023. PMID: 37971875 Free PMC article.
Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial.
Lee E, Coulter J, Mishra A, Caramella-Pereira F, Demarzo A, Rudek M, Hu C, Han M, DeWeese TL, Yegnasubramanian S, Song DY. Lee E, et al. Among authors: yegnasubramanian s. Trials. 2023 Dec 16;24(1):809. doi: 10.1186/s13063-023-07838-4. Trials. 2023. PMID: 38104131 Free PMC article.
Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
Skinner NE, Ogega CO, Frumento N, Clark KE, Paul H, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE Jr, Ray SC, Bailey JR. Skinner NE, et al. Among authors: yegnasubramanian s. Front Immunol. 2023 Apr 25;14:1201033. doi: 10.3389/fimmu.2023.1201033. eCollection 2023. Front Immunol. 2023. PMID: 37180140 Free PMC article.
Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis.
Rajeh A, Cornman HL, Gupta A, Szeto MD, Kambala A, Oladipo O, Parthasarathy V, Deng J, Wheelan S, Pritchard T, Kwatra MM, Semenov YR, Gusev A, Yegnasubramanian S, Kwatra SG. Rajeh A, et al. Among authors: yegnasubramanian s. medRxiv [Preprint]. 2023 Sep 26:2023.09.25.23295810. doi: 10.1101/2023.09.25.23295810. medRxiv. 2023. PMID: 37808834 Free PMC article. Preprint.
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.
Skinner NE, Ogega CO, Frumento N, Clark KE, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE Jr, Ray SC, Bailey JR. Skinner NE, et al. Among authors: yegnasubramanian s. Front Immunol. 2023 Mar 24;14:1135841. doi: 10.3389/fimmu.2023.1135841. eCollection 2023. Front Immunol. 2023. PMID: 37033983 Free PMC article.
CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine.
Karantanos T, Teodorescu P, Arvanitis M, Perkins B, Jain T, DeZern AE, Dalton WB, Christodoulou I, Paun BC, Varadhan R, Esteb C, Rajkhowa T, Bonifant C, Gondek LP, Levis MJ, Yegnasubramanian S, Ghiaur G, Jones RJ. Karantanos T, et al. Among authors: yegnasubramanian s. Haematologica. 2023 Jul 1;108(7):1886-1899. doi: 10.3324/haematol.2022.281444. Haematologica. 2023. PMID: 36519323 Free PMC article.
Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells.
Singh AK, Wang R, Lombardo KA, Praharaj M, Bullen CK, Um P, Gupta M, Srikrishna G, Davis S, Komm O, Illei PB, Ordonez AA, Bahr M, Huang J, Gupta A, Psoter KJ, Creisher PS, Li M, Pekosz A, Klein SL, Jain SK, Bivalacqua TJ, Yegnasubramanian S, Bishai WR. Singh AK, et al. Among authors: yegnasubramanian s. iScience. 2023 Aug 24;26(10):107733. doi: 10.1016/j.isci.2023.107733. eCollection 2023 Oct 20. iScience. 2023. PMID: 37674985 Free PMC article.
170 results